GB1455578A - Process for the reduction of 3-keto-steroids - Google Patents

Process for the reduction of 3-keto-steroids

Info

Publication number
GB1455578A
GB1455578A GB5364273A GB5364273A GB1455578A GB 1455578 A GB1455578 A GB 1455578A GB 5364273 A GB5364273 A GB 5364273A GB 5364273 A GB5364273 A GB 5364273A GB 1455578 A GB1455578 A GB 1455578A
Authority
GB
United Kingdom
Prior art keywords
reduction
keto
steroids
steroid
nov
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5364273A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of GB1455578A publication Critical patent/GB1455578A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB5364273A 1972-11-18 1973-11-19 Process for the reduction of 3-keto-steroids Expired GB1455578A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2257132A DE2257132C3 (de) 1972-11-18 1972-11-18 Verfahren zur Reduktion von 3-Ketosteroiden

Publications (1)

Publication Number Publication Date
GB1455578A true GB1455578A (en) 1976-11-17

Family

ID=5862375

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5364273A Expired GB1455578A (en) 1972-11-18 1973-11-19 Process for the reduction of 3-keto-steroids

Country Status (11)

Country Link
US (1) US3875195A (US07413550-20080819-C00001.png)
JP (1) JPS5710879B2 (US07413550-20080819-C00001.png)
CH (1) CH586237A5 (US07413550-20080819-C00001.png)
CS (1) CS166850B2 (US07413550-20080819-C00001.png)
DD (1) DD108080A5 (US07413550-20080819-C00001.png)
DE (1) DE2257132C3 (US07413550-20080819-C00001.png)
DK (1) DK134782C (US07413550-20080819-C00001.png)
FR (1) FR2207129A1 (US07413550-20080819-C00001.png)
GB (1) GB1455578A (US07413550-20080819-C00001.png)
HU (1) HU166940B (US07413550-20080819-C00001.png)
NL (1) NL7315781A (US07413550-20080819-C00001.png)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031117A (en) * 1975-09-22 1977-06-21 Becton, Dickinson And Company Testosterone derivatives
JPS60135172U (ja) * 1984-02-20 1985-09-07 株式会社エバニュ− ロ−ラ−スケ−トの車輪
JPS60135171U (ja) * 1984-02-20 1985-09-07 株式会社エバニュ− ロ−ラ−スケ−トの車輪
JP2545522B2 (ja) * 1985-10-23 1996-10-23 アルコン・ラボラトーリーズ,インコーポレイテッド テトラヒドロ脈管形成抑制ステロイド
JPH01130377U (US07413550-20080819-C00001.png) * 1988-02-24 1989-09-05
EP1558627B1 (en) * 2002-10-28 2010-03-03 Phytopharm Plc Stereospecific reduction of sapogen-3-ones

Also Published As

Publication number Publication date
JPS4981360A (US07413550-20080819-C00001.png) 1974-08-06
JPS5710879B2 (US07413550-20080819-C00001.png) 1982-03-01
CH586237A5 (US07413550-20080819-C00001.png) 1977-03-31
DD108080A5 (US07413550-20080819-C00001.png) 1974-09-05
FR2207129A1 (US07413550-20080819-C00001.png) 1974-06-14
US3875195A (en) 1975-04-01
DK134782B (da) 1977-01-17
HU166940B (US07413550-20080819-C00001.png) 1975-06-28
DE2257132C3 (de) 1982-05-13
DK134782C (da) 1977-06-06
DE2257132A1 (de) 1974-05-30
NL7315781A (US07413550-20080819-C00001.png) 1974-05-21
DE2257132B2 (de) 1981-07-23
CS166850B2 (US07413550-20080819-C00001.png) 1976-03-29

Similar Documents

Publication Publication Date Title
GB1222037A (en) Catalytic hydrogenation of di(4-aminophenyl)methane
GB1456838A (en) 16,17,18,19,20-pentanorprostaglandins
CA956973A (en) Process for preparing 1,3-butadiene and methacrolein simultaneously
GB1455578A (en) Process for the reduction of 3-keto-steroids
GB1300889A (en) Hydrogenation of carboxylic acids
GB1229707A (US07413550-20080819-C00001.png)
CA951873A (en) Process for producing aqueous hydrogen peroxide solutions
GB1381837A (en) Process for the manufacture of triacetone-amine
GB1323374A (en) Preparation of 2-pyrrolidinone
GB1243327A (en) Process for the preparation of piperidine
GB1366187A (en) Preparation of 2-pyrrolidinone
GB1419767A (en) Cobalt oxide catalysts
GB1365035A (en) Process for producing 2 3 6-trimethylhydroquinone
GB1379719A (en) Method for the production of hydroquinone
GB1450425A (en) Process for the manufacture of beta-3-oxo-7alpha-acetylthio- 17beta-hydroxy-4-androsten-17alpha-yl- -propionic acid ypsilon- lactone and an intermediate in its production
GB1326402A (en) Process for producing 5-alkylidene-2-norbornenes
CA954463A (en) Process for producing citric acid by fermentation
GB1205141A (en) Process for producing monoethylamine
FR2318149B1 (US07413550-20080819-C00001.png)
ES339690A1 (es) Procedimiento para la preparacion de 17 alfa-aciloxi-21- hidroxiesteroides de la serie de pregnano.
ES411143A1 (es) Un procedimiento para la produccion de 3-fluor-d-alanina y sus deutero-analogos.
ES437233A1 (es) Un procedimiento para la preparacion de d-homoesteroides.
GB1300971A (en) A method of making a silver catalyst for use in the production of ethylene oxide
GB1291037A (en) 7beta-METHYLSTEROIDS
GB1400719A (en) Supported nickel catalysts

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee